# Biorepository and Molecular Pathology (BMP)

> **NIH NIH P30** · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · 2020 · $248,276

## Abstract

BIOREPOSITORY AND MOLECULAR PATHOLOGY SHARED RESOURCE
ABSTRACT
The Biorepository and Molecular Pathology Shared Resource (BMP) contributes to cancer research at
Huntsman Cancer Institute (HCI) by collecting, storing, tracking, processing, and distributing biospecimens
obtained from cancer patients receiving treatment at the University of Utah (U of U). Established in 2000, BMP
provides the critical expertise and resources to integrate biorepository, histology, and advanced molecular
diagnostics services toward the support of the clinical, translational, and basic science research at HCI. The
biospecimens provided by BMP are an essential component of HCI research projects that seek to understand
cancer mechanisms and develop new methods of treatment. BMP’s aims are 1) to serve as a state-of-the-art,
centralized biobanking resource for the collection, processing, storage, distribution, and analysis of human
biospecimens; and 2) to support the scientific research objectives of the Cancer Center by providing
researchers with cost-effective access to high-quality, clinically annotated biospecimens and their derivatives
for research studies. BMP is directed by Chris Fillmore, PhD. Management of BMP within the Cancer Center
ensures that this Resource is focused on addressing the needs of Cancer Center members.
BMP has three sections: 1) Biorepository, 2) Research Histology (RH), and 3) Molecular Diagnostics (MD),
united through pathology-based services on human biospecimens obtained from patients receiving clinical care
at the U of U. The College of American Pathologists accredited Biorepository Section provides investigators
with high-quality, thoroughly annotated fresh tumor samples, blood, and other body fluids with patient-matched
normal controls, using methods that ensure adept procurement, processing, storage, and prioritized
distribution. RH, separate from hospital histology, performs expert histology on all types of frozen and fixed
human tissues derived via the Biorepository. MD provides cutting-edge molecular diagnostic tests utilizing the
latest technologies. It uses biospecimens and histologic preparations from the other two BMP sections for
nucleic acid isolation and genetic analysis. The Biorepository manages a centralized collection of >500,000
samples: 346,000 blood or fluid samples, 116,000 tissue specimens, and 50,000 formalin-fixed, paraffin-
embedded blocks, all cancer-related. Currently, 6,000 cancer patient samples are collected, processed, and
banked each year by BMP. Over 23% of BMP’s users are Cancer Center members with peer-reviewed
funding, and 92% of users are cancer-related. Since 2014, over 55 publications have included work supported
by BMP. The Resource advances cancer research at HCI by providing services at highly competitive costs.
The Shared Resource adds substantial value to HCI's research efforts and is central to HCI’s goals to improve
cancer diagnosis, treatment, and cures.

## Key facts

- **NIH application ID:** 9935883
- **Project number:** 2P30CA042014-31
- **Recipient organization:** UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
- **Principal Investigator:** Gary Christopher Fillmore
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $248,276
- **Award type:** 2
- **Project period:** — → —

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9935883

## Citation

> US National Institutes of Health, RePORTER application 9935883, Biorepository and Molecular Pathology (BMP) (2P30CA042014-31). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/9935883. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*